Insider · CIK 0001893193
Dara Richardson-Heron
Files at CRBU (Caribou Biosciences, Inc.). First filing -, latest -.
In brief
Dara Richardson-Heron files SEC Form 4 as director at CRBU (Caribou Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dara Richardson-Heron has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +45,000 | $0.00 | $0 | 45,000 | Feb 20, 2026 |
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +40,500 | $0.00 | $0 | 40,500 | Feb 21, 2025 |
Questions about Dara Richardson-Heron
Answered from the filings on this page, as of the latest one.
Is Dara Richardson-Heron buying or selling?
Dara Richardson-Heron has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dara Richardson-Heron's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dara Richardson-Heron has 0.
Where does Dara Richardson-Heron file Form 4?
Dara Richardson-Heron has filed Form 4 at CRBU (Caribou Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.